Are digital therapeutics (DTx) the future of mental health care?
Originally presented at the DTx West 2021 Conference on February 25th 2021.

Join Big Health’s Dr. Jenna Carl, VP of Clinical Development and Medical Affairs as she moderates a panel discussion with Dr. Andrew Krystal of UCSF, Dr. Juliette McClendon from Boston University, Dr. Jordan Silberman from Anthem, and Brian Dolan from Exits and Outcomes, on the importance of clinical evidence to the future of digital therapeutics.
Don’t have time to watch the full video? We got your back. Check out our blog highlighting the key takeaways from the panel.
Here’s our latest

Navigating the Employee Benefits Ecosystem
Benefits leaders are faced with the unique challenge of expanding access to mental health care by reaching employees in the…

Can technology be the modern solution for certain mental health conditions?
In past years, the use of technology in healthcare has become an effective tool to expand the reach of mental…

The state of women in the workplace hangs in the balance
Women face an array of unique stressors — many of which have been compounded by the COVID-19 pandemic. This reality…